• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革兰氏染色在评估囊性纤维化患者痰液中的应用。

Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

作者信息

Sadeghi E, Matlow A, MacLusky I, Karmali M A

机构信息

Department of Microbiology, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

J Clin Microbiol. 1994 Jan;32(1):54-8. doi: 10.1128/jcm.32.1.54-58.1994.

DOI:10.1128/jcm.32.1.54-58.1994
PMID:7510312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC262969/
Abstract

The utility of sputum Gram stain in assessing salivary contamination and in predicting the presence of pathogens on the basis of morphology was investigated in 287 respiratory specimens from patients with cystic fibrosis. Where acceptability for culture was defined as a leukocyte/squamous epithelial cell ratio of > 5, 76.6% (220 of 287) of respiratory specimens received in the laboratory were considered acceptable. Unacceptable specimens were more common in younger patients. The positive predictive value of the Gram stain for growth from acceptable sputum samples was 98% for Pseudomonas aeruginosa, 84.4% for Pseudomonas cepacia, 86.3% for Staphylococcus aureus, and 100% for Haemophilus influenzae. In cystic fibrosis patients, as has been reported for respiratory specimens in general, Gram stain of respiratory specimens in helpful for interpreting culture results.

摘要

在287份来自囊性纤维化患者的呼吸道标本中,研究了痰革兰氏染色在评估唾液污染以及根据形态学预测病原体存在方面的效用。若将培养的可接受性定义为白细胞/鳞状上皮细胞比率大于5,则实验室收到的呼吸道标本中有76.6%(287份中的220份)被认为是可接受的。不可接受的标本在年轻患者中更为常见。对于可接受痰标本的培养生长,革兰氏染色对铜绿假单胞菌的阳性预测值为98%,对洋葱伯克霍尔德菌为84.4%,对金黄色葡萄球菌为86.3%,对流感嗜血杆菌为100%。在囊性纤维化患者中,正如一般呼吸道标本所报道的那样,呼吸道标本的革兰氏染色有助于解释培养结果。

相似文献

1
Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.革兰氏染色在评估囊性纤维化患者痰液中的应用。
J Clin Microbiol. 1994 Jan;32(1):54-8. doi: 10.1128/jcm.32.1.54-58.1994.
2
Utility of gram staining for evaluation of the quality of cystic fibrosis sputum samples.革兰氏染色在评估囊性纤维化痰液样本质量中的应用。
J Clin Microbiol. 2002 Aug;40(8):2791-4. doi: 10.1128/JCM.40.8.2791-2794.2002.
3
Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis?物理治疗后的咽拭子能否替代痰液用于囊性纤维化患儿微生物病原体的鉴定?
Indian J Pediatr. 2004 Jan;71(1):21-3. doi: 10.1007/BF02725650.
4
[Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].[从囊性纤维化患者中分离出洋葱伯克霍尔德菌的频率]
Mikrobiyol Bul. 2002 Jan;36(1):1-10.
5
Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia - Brazil.巴西巴伊亚年轻囊性纤维化患者的中鼻道与痰的微生物学比较。
Braz J Infect Dis. 2014 Mar-Apr;18(2):215-9. doi: 10.1016/j.bjid.2013.07.006. Epub 2013 Nov 22.
6
Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis.囊性纤维化患者呼吸道病原体的流行情况和药敏分析。
Braz J Infect Dis. 2010 Jul-Aug;14(4):406-9.
7
[Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].[囊性纤维化儿科患者呼吸道样本中的细菌分离株及其年龄分布]
Rev Argent Microbiol. 2013 Jan-Mar;45(1):44-9.
8
Retrospective analysis of microorganisms isolated from cystic fibrosis patients in Southern Italy, 2002-2010.2002年至2010年意大利南部囊性纤维化患者分离出的微生物回顾性分析。
J Prev Med Hyg. 2011 Dec;52(4):209-14.
9
Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.通过荧光原位杂交技术对囊性纤维化患者临床样本中的细菌进行特异性快速检测。
J Clin Microbiol. 2000 Feb;38(2):818-25. doi: 10.1128/JCM.38.2.818-825.2000.
10
Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.用于检测囊性纤维化患者痰液样本中细菌病原体的传统方法与分子方法的比较。
FEMS Immunol Med Microbiol. 2000 Jan;27(1):51-7. doi: 10.1111/j.1574-695X.2000.tb01411.x.

引用本文的文献

1
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.临床微生物学实验室实用指南:更新的囊性纤维化患者呼吸道样本处理指南。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0021521. doi: 10.1128/cmr.00215-21. Epub 2024 Aug 19.
2
Comparison of methods for the analysis of airway macrophage particulate load from induced sputum, a potential biomarker of air pollution exposure.诱导痰气道巨噬细胞颗粒负荷分析方法的比较,空气污染暴露的一种潜在生物标志物。
BMC Pulm Med. 2015 Nov 5;15:137. doi: 10.1186/s12890-015-0135-7.
3
Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.中性粒细胞在感染性囊性纤维化痰液中产生的一氧化氮会消耗氧气。
Clin Exp Immunol. 2014 Jul;177(1):310-9. doi: 10.1111/cei.12318.
4
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.直接采样囊性纤维化肺组织表明,基于 DNA 的上呼吸道标本分析可能会对肺部微生物群产生误判。
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13769-74. doi: 10.1073/pnas.1107435109. Epub 2012 Aug 7.
5
Diagnostic test for etiologic agents of community-acquired pneumonia.社区获得性肺炎病原体的诊断检测
Infect Dis Clin North Am. 2004 Dec;18(4):809-27. doi: 10.1016/j.idc.2004.08.002.
6
Usefulness of Gram stain for diagnosis of lower respiratory tract infection or urinary tract infection and as an aid in guiding treatment.革兰氏染色在诊断下呼吸道感染或尿路感染以及辅助指导治疗方面的实用性。
Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):228-34. doi: 10.1007/s10096-003-0892-8. Epub 2003 Mar 25.
7
Utility of gram staining for evaluation of the quality of cystic fibrosis sputum samples.革兰氏染色在评估囊性纤维化痰液样本质量中的应用。
J Clin Microbiol. 2002 Aug;40(8):2791-4. doi: 10.1128/JCM.40.8.2791-2794.2002.
8
Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.囊性纤维化患者痰液样本中检测洋葱伯克霍尔德菌的培养法与聚合酶链反应法比较
J Clin Microbiol. 1998 Jun;36(6):1642-5. doi: 10.1128/JCM.36.6.1642-1645.1998.

本文引用的文献

1
Ordering patterns, collection, transport, and screening of sputum cultures in a community hospital: evaluation of methods to improve results.社区医院痰培养的送检模式、采集、运输及筛查:改善结果的方法评估
Infect Control. 1981 Jul-Aug;2(4):307-11. doi: 10.1017/s019594170005534x.
2
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.囊性纤维化患者痰液的细菌学:二硫苏糖醇作为黏液溶解剂的评估
J Clin Microbiol. 1980 Jun;11(6):552-7. doi: 10.1128/jcm.11.6.552-557.1980.
3
Abnormal morphology of bacteria in the sputa of patients treated with antibiotics.接受抗生素治疗患者痰液中细菌的形态异常。
J Clin Microbiol. 1982 Aug;16(2):382-6. doi: 10.1128/jcm.16.2.382-386.1982.
4
Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.
J Infect Dis. 1984 Feb;149(2):283. doi: 10.1093/infdis/149.2.283.
5
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.囊性纤维化中的洋葱伯克霍尔德菌感染:一个新出现的问题。
J Pediatr. 1984 Feb;104(2):206-10. doi: 10.1016/s0022-3476(84)80993-2.
6
Etiological diagnosis of bacterial pneumonia by gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity.通过痰液革兰氏染色和定量培养进行细菌性肺炎的病因诊断。以白细胞或肺泡巨噬细胞作为样本代表性的指标。
Scand J Infect Dis. 1983;15(2):153-60. doi: 10.3109/inf.1983.15.issue-2.05.
7
Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.囊性纤维化患者气道分泌物的流变学和传输特性——与感染程度和疾病严重程度的关系
Eur J Clin Invest. 1985 Dec;15(6):389-94. doi: 10.1111/j.1365-2362.1985.tb00290.x.
8
Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis.囊性纤维化患者气道分泌物脂质含量与流变学特性之间的关系。
Clin Chim Acta. 1987 Apr 30;164(2):139-49. doi: 10.1016/0009-8981(87)90065-9.
9
Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.囊性纤维化患者痰液中细菌生长与无污染支气管内样本的一致性。
Thorax. 1986 Aug;41(8):641-6. doi: 10.1136/thx.41.8.641.
10
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.从囊性纤维化患者呼吸道标本中分离出唐菖蒲假单胞菌。
J Clin Microbiol. 1989 Feb;27(2):270-3. doi: 10.1128/jcm.27.2.270-273.1989.